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Circadian rhythm of arterial blood pressure and albuminuria in
diabetic nephropathy. The aim of our study was to evaluate the diurnal
relationship between arterial blood pressure and albuminuria, and some
potential mechanisms responsible for impaired nocturnal blood pressure
reduction (non-dippers, groups I and II) in diabetic nephropathy (DN).
Twenty-four-hour ambulatory blood pressure, heart rate (HR) variation
(autonomic nervous function) and extracellular fluid volume (ECV) were
measured, and urine samples were collected three times during the
corresponding day- and nighttimes in 47 insulin-dependent diabetic
(IDDM) patients with DN. Mean arterial blood pressure (MABP) during
the daytime [mm Hg, median (range)I was identical in group I 105
(96—137)1, group II [109 (86—124)1 and group III [dippers; average blood
pressure reduction from day to night> 10%, 107 (93—132), P = NS], while
the nighttime MABP differed [group I, 106 (95—144); group II, 100
(78—118); group III, 91(76—118); P < 0.001]. No significant difference
between the groups concerning the daytime or nighttime albuminuria
[Lg/min; median (range)] was observed; [Day: group 1, 1467 (235—3933);
group II, 695 (170—6719); group III, 875 (228—3173). Night: group I, 1079
(279—4665); group II, 572 (113—3807); group III, 659 (81—2493)]. A
significant correlation between MABP and albuminuria was demonstrated
during day- (p = 0.50, P < 0.0005) and nighttime (p = 0.46, P < 0.005),
while neither the absolute nor the relative changes in MABP from day to
night correlated significantly with absolute or relative changes in albumin-
uria from day to night. The night/day ratio of HR was higher in group I
[0.93 (0.76—1.09), median (range)] compared to group III [0.83 (0.74—
1.02), P < 0.005] and a significant correlation between this ratio and the
night/day ratio of MABP was found (p = 0.54, P < 0.0005). ECV was
about the same in the three groups. Our study indicated an association
between blood pressure and albuminuria, but the mechanisms involved in
the reduction of albuminuria from day to night was not unraveled. A
relative lack of sympathetic withdrawal during sleep seems to be an
important feature of nocturnal hypertension in diabetic nephropathy.
Diurnal variations in arterial blood pressure and urinary albu-
min excretion rate are present in normal subjects and patients
with diabetic or non-diabetic glomerulopathies [1—6]. The normal
reduction from day to night varies between 10 to 30% in arterial
blood pressure and between 20 to 40% for the urinary albumin
excretion rate. Recent studies have demonstrated that insulin-
dependent diabetic (IDDM) and non-insulin-dependent diabetic
(NIDDM) patients suffering from diabetic nephropathy fre-
quently have blunted nocturnal arterial blood pressure reduction
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[1, 7—9]. These changes may induce a blunted nocturnal reduction
in albuminuria, particularly in patients with impaired renal auto-
regulation, as demonstrated in IDDM patients with diabetic
nephropathy [10]. Autonomic dysfunction has been suggested to
play a role in the genesis of blunted nocturnal reduction in arterial
blood pressure [11 and in urinary albumin excretion rate in IDDM
patients without nephropathy [11]. The pathophysiological factors
leading to blunted nocturnal arterial blood pressure reduction are
likely to be multifactorial, as suggested by the recent finding that
latent fluid retention may contribute to nocturnal hypertension in
diabetic nephropathy [121.
Our study aimed to elucidate a possible relationship between
day to night changes in arterial blood pressure and day to night
changes in the urinary albumin excretion rate, and to examine
some potential mechanisms responsible for the impaired noctur-
nal arterial blood pressure reduction in IDDM patients with
diabetic nephropathy.
Methods
Patients
Forty-seven consecutive IDDM patients with diabetic nephrop-
athy, who fulfilled the following inclusion criteria were enrolled in
the present study: persistent albuminuria > 300 mg/24 hr, glomer-
ular filtration rate (GFR) 25 ml min1 . 1.73 m2, an average
of three or more consecutive diastolic blood pressure readings
105 mm Hg, without antihypertensive treatment (except furo-
semide, N = 10), and age between 18 to 55 years. Patients were
excluded if they had a previous history of stroke and/or transient
ischemic attacks, congestive heart failure (NYHA III-IV), myo-
cardial infarction or coronary bypass surgery within the last three
months, and/or an unstable angina pectoris. All patients had been
insulin-dependent from the time of diagnosis and all were receiv-
ing at least two daily injections of insulin. Diabetic nephropathy
was diagnosed clinically if the following criteria were fulfilled:
persistent albuminuria above 300 mg/24 hr, presence of diabetic
retinopathy and no clinical or laboratory evidence of other kidney
or renal tract disease, other than diabetic glomerulosclerosis [13].
Diabetic retinopathy was evaluated by fundus photography (Can-
on CFD-602, Kawasaki, Japan) after pupillary dilatation and
graded as none, simplex or proliferative. Thirty-five patients had
received antihypertensive treatment for at least two years; 26
patients were treated with an angiotensin converting enzyme
inhibitor (ACE!) either alone (N = 7) or in combination with one
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or more conventional antihypertensive drugs (diuretics, calcium
channel blockers, selective /3-blockers, a-blockers). Nine patients
were treated with conventional antihypertensive drugs (see
above). Three newly diagnosed hypertensive patients did not
receive antihypertensive treatment. Nine patients were normoten-
sive. Patients were divided according to the nocturnal reduction in
arterial blood pressure in non-dippers (groups I and II) and
dippers (group III). Non-dippers were defined as subjects with an
average reduction in systolic and diastolic blood pressure from
day to night of 10% [14]. The non-dippers were furthermore
divided into two groups, group I below and group II above the
median. All patients participating in the study were Caucasians,
and all gave informed consent to participate in the study. The
study was approved by the Regional Ethics Committee.
Methods
If treatment was given, all antihypertensive drugs were with-
drawn four weeks before examination, except in ten patients
receiving furosemide because of overt edemata. Three consecu-
tive 24-hour urine samples were collected. They were all divided
into day- and nighttime portions according to the actual bed
times. The content of urinary albumin and sodium were measured
by using an enzyme-linked immunoadsorbent assay [151 and a
flame photometric method (Flame photometer FLM 3; Radiom-
eter, Copenhagen, Denmark), respectively. Twenty-four-hour am-
bulatory blood pressure was measured simultaneously with the
third 24-hour urine collection, at the homes of the patients, with
a Takeda TM2420 device version 6 or 7 (A&D, Tokyo, Japan)
[16—18]. A cuff size of 20 to 31 cm was used in patients with an
arm circumference less than 32 cm and a cuff size of 28 to 36 cm
was used in patients with an arm circumference above 32 cm.
Blood pressures and heart rates were measured every 15 minutes
during the daytime (0700 to 2300 hours) and every 30 minutes
during the nighttime (2300 to 0700 hours) [19]. Twenty-four-hour
blood pressure measurements were accepted if at least 50% of the
programmed pressures were measured successfully for each hour
during the whole 24-hour monitoring interval. No editing was
performed in the recorded blood presure values. Values were
averaged for each hour before calculating day, night and 24-hour
blood pressure. The mean arterial blood pressure was calculated
as one-third of the difference betwr .n systolic and diastolic blood
pressure plus the diastolic blood pressure.
The between visits coefficient of variation for ambulatory blood
pressure (ABP) monitoring for systolic blood pressure was: 24-
hour 6%, daytime 6%, nighttime 7%; for diastolic blood pressure
the ABP was: 24-hour 8%, daytime 11%, and nighttime 10%.
Cardiac autonomic nervous function (primarily parasympa-
thetic) was assessed by the beat-to-beat variation during deep
breathing [< 4 beats min (abolished), 5 to 15 beats min1
(impaired) and > 15 beats min1 (normal)] [20, 21]. The
coefficient of variation for beat-to-beat variation during deep
breathing is 24% in our laboratory. As an overall indicator, mainly
of cardiac and neurohumeral sympathetic activity, we determined
the night/day ratio of heart rate [22, 23]. Determination of the
GFR and extracellular fluid volume (ECV) were performed with
the patients in the supine position between 8 a.m and 1 p.m., after
an overnight fast. Patients had breakfast and morning insulin 30
minutes after the start of the investigation, and drank approxi-
mately 200 ml of tap water per hour during the investigation
period. GFR was measured after a single intravenous injection of
3.7 MBq 5Cr-labeled eidetic acid (51Cr-EDTA) at 8 a.m., by
determining the radioactivity in venous blood samples 180, 200,
220 and 240 minutes after the injection [24, 25]. Extracellular fluid
volume was determined to be the distribution volume of 51Cr-
EDTA [26]. The results were standardized for 1.73 m2 body
surface area. The mean intra-individual coefficient of variation of
the glomerular filtration rate and extracellular fluid volume from
day to day is 4% and 15%, respectively, in our laboratory. Body
mass index (BMI) was calculated as weight (kg) height (m)2.
From venous blood samples hemoglobin A1 (HbA1) was mea-
sured by high-performance liquid chromatography (DIAMAT
analyzer; Bio-Rad, CA, USA). The normal range of HbA1C in our
laboratory is 4.1 to 6.4%.
Statistical analysis
All data are expressed as median (range), except when indi-
cated. The Mann-Whitney U-test and the Kruskal-Wallis test of
variance was used to test for differences between two and three
groups, respectively. The Wilcoxon signed-ranks test was used to
test paired data. For each patient the night and day urinary
albumin excretion rates and the urinary sodium excretion rate are
expressed as the median of three night and day collections,
respectively. Correspondingly, the night/day ratios of the urinary
albumin excretion rate and urinary sodium excretion rate for each
patient are represented as the median of three night/day ratios.
The chi-square test was used for evaluating frequencies. Spear-
man's rank correlation coefficient was used for correlations,
except when indicated. All calculations were made using Stat-
graphics (STSC; Rockville, MD, USA). A P value of < 0.05 was
considered significant (two-tailed).
Results
The three groups with different nocturnal arterial blood pres-
sure reduction were similar with respect to the following: sex ratio,
age, duration of diabetes, HbAIC, BMI, insulin dosage, duration of
diabetic nephropathy and level of retinopathy (Table 1). Further-
more, the nine normotensive patients were equally distributed
among the three groups.
There was a significant decline in MABP from 107 (86—137)
mm Hg during daytime to 100 (76—144) mm Hg during nighttime(P < 0.0001) in the whole group of patients. A similar diurnal
pattern was observed in albuminuria: 1123 (170—6719) jsg min1
(daytime) versus 841 (81—4665) jsg min1 (nighttime) (P <
0.0001). The median glomerular filtration rate was 82 (32—139) ml
min1 1.73 m2 and the median extracellular fluid volume was
14.0 (11.0 —18.5) liters• 1.73 m2. Table 2 illustrates the results in
the three groups of patients. Daytime MABP and 24-hour MABP
values were alike in the three groups. The daytime heart rate
(HR) was comparable in the three groups, while the nighttime
HR tended to be highest in group I and lowest in group III, with
group II in-between (P = 0.09). The night/day ratio of HR was
higher in group I compared to group III (P < 0.005). Further-
more, we found a correlation between the night/day ratio of HR
and the night/day ratio of arterial blood pressure (p =0.54, P <
0.0005; Fig. 1). Group I, completely lacking nocturnal blood
pressure reduction, tended to have the highest albumin excretion
rate both during night- and daytimes (P < 0.15, comparing group
I vs. group III). No significant differences were found in the ratio
of night to day urinary excretion rates of albuminuria and sodium
between the three groups. Glomerular filtration rate, extracellular
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Table 1. Clinical characteristics of 47 IDDM patients with diabetic nephropathy
Group I
N=16 Group IIN=15 Group IIIN=16 P
Sex (F/M) 7/9 5/10 5/11 NS
Age years 37 (2 1—53) 39 (26—59) 39 (28—55) NS
Duration of diabetes years 24 (15—46) 23 (16—39) 22 (14—34) NS
HbA1, % 9.4 (8.1—12.2) 9.7 (7.0—10.8) 8.8 (6.5—11.3) NS
Body mass index kg m2 24.8 (19.5—37.1) 25.2 (19.8—32.6) 24.9 (19.7—30.1) NS
Insulin dosage U kg' day' 0.64 (0.44—1.24) 0.64 (0.42—0.96) 0.65 (0.34—0.89) NS
Duration of persistent albuminuria years 6 (1—19) 6 (4-12) 6 (2—15) NS
Retinopathy (simplex/proliferative) 4/12 5/10 9/7 NS
No. of patients receiving furosemidea
Furosemide dose mg daily'
3
240 (200—500)
2
395 (40—750)
5
80 (40—1000)
NS
NS
Data are median (range).
Patients are divided according to the nocturnal reduction in arterial blood pressure in non-dippers (group I and II) and dippers (group III).
Non-dippers are defined as subjects with an average reduction in systolic and diastolic blood pressure from day to night of 10%. The non-dippers
are furthermore divided into two groups, group I below and group II above the median.
a At time of investigation
b Only patients receiving furosemide
Table 2. Mean arterial blood pressure (MABP), mean heart rate (HR), albuminuria (UAE), urinary sodium excretion rate (UNaE), glomerular
filtration rate (GFR), extracellular fluid volume (ECV), and cardiac autonomic nervous function (beat-to-beat) in 47 IDDM patients with
diabetic nephropathy
Group I
N=16
Group II
N=15
Group III
N=16 P
24-Hour MABP mm Hg
Nighttime MABP mm Hg
105 (96—140)
106 (95—144)
107 (83—122)
100 (78—118)
102 (89—128)
91(76—118)
NS
<0.00051,c
Daytime MABP mm Hg
Night/day MABP
24-Hour HR beats min'
Nighttime HR beats min'
Daytime HR beats min1
105 (96—137)
1.00 (0.95—1.18)
87 (65—103)
83 (55—98)
88 (71—106)
109 (86—124)
0.92 (0.90—0.95)
86 (74—95)
80 (66—91)
90 (77—98)
107 (93—132)
0.84 (0.75—0.89)
84 (66—99)
74 (53—87)
89 (72—106)
NS
<00001a,b,c
NS
0.09
NS
Night/day HR 0.93 (0.76—1.09) 0.90 (0.76—1.00) 0.83 (0.74—1.02) <0.005c
24-Hour UAE mg 1980 (394—5485) 868 (238—7716) 1231 (297—4149) NS
Nighttime UAE pg min' 1079 (279—4665) 572 (113—3807) 659 (81—2493) NS
Daytime UAE pg min' 1467 (235—3933) 695 (170—6719) 875 (228—3173) NS
Night/day UAE
Nighttime UNaE pmol min'
Daytime UNaE pinol min'
0.78 (0.51—1.99)
139 (32—269)
91 (28—191)
0.63 (0.19—1.56)
147 (25—253)
127 (53—357)
0.70 (0.35—2.83)
107 (43—417)
130 (41—244)
NS
NS
NS
Night/day UNaE
GFR m1 min' 1.73 m2
1.33 (0.43—3.65)
86(49—121)
0.79 (0.21—2.64)
74(40—124)
0.88 (0.19—4.01)
95 (32—139)
NS
NS
ECV 1iter 1.73 m2 13.4 (11.8—18.5) 13.5 (11.8—18.0) 14.3 (11.0—16.8) NS
ECV % of bodyweight 19.5 (16.5—26.9) 20.9 (15.1—27.5) 21.0 (17.4—24.7) NS
Beat-to-beat beats min1 5 (0—25) 6 (2—16) 7 (1—15) NS
Data are median (range).
Patients are divided according to the nocturnal reduction in arterial blood pressure in non-dippers (group I and II) and dippers (group III).
Non-dippers are defined as subjects with an average reduction in systolic and diastolic blood pressure from day to night of 10%. The non-dippers
are furthermore divided into two groups, group I below and group II above the median.
aBetween group I—IlhBetween group Il—Ill
Between group I—Ill
fluid volume and beat-to-beat variation during deep breathing
were about the same in all three groups.
Significant correlations between daytime MABP and daytime
albuminuria (p = 0.52, P < 0.0005; Fig. 2), between nighttime
MABP and nighttime albuminuria (p = 0.46, P < 0.005; Fig. 2),
and between 24-hour MABP and 24-hour albuminuria (p 0.57,
P < 0.0005) were found. No significant correlations between the
night/day ratio of MABP and night/day ratio of albuminuria (p =
0.02, P = 0.89; Fig. 3), between nighttime MABP minus daytime
MABP and nighttime albuminuria minus daytime albuminuria (p
=
—0.14, P = 0.35), or between log (nighttime albuminuria)/log
(daytime albuminuria) and night/day ratio of MABP (r = 0.08,
P = 0.59, linear regression) were found.
The 47 patients were divided into two groups according to the
median value of ECV (14.0 liter 1.73 m2). One group of
patients had an ECV below the median and another group of
patients an ECV above the median. Clinical and laboratory
characteristics of the two groups were comparable, except the
extracellular fluid volume (Table 3). In both groups there was a
significant reduction in systolic and diastolic blood pressure from
day to night of 5%/5% in patients with an ECV below the median
and 8%/9% in patients with an ECV above, respectively. The
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night/day ratio of systolic and diastolic blood pressure was not
significantly different between the two groups (Table 3). The
degree of nocturnal reduction in arterial blood pressure was
normally distributed in both groups. The difference in nocturnal
arterial blood pressure reduction between patients with an ECV
below and above the median, was —3.4% with a 95% confidence
interval from —8.5 to 1.7%. The urinary sodium excretion rate
tended to be lower in patients with an ECV below the median
compared with patients with an ECV above (P < 0.06) during
daytime, but was the same during nighttime (Table 3). Omitting
the ten patients treated with furosemide had no significant impact
on the variables presented in Table 3.
Discussion
Our cross-sectional study in IDDM patients with diabetic
nephropathy revealed an impaired nocturnal arterial blood pres-
sure reduction in the majority of the patients, a relationship
between arterial blood pressure and albuminuria during the day
and night measurements, and a lack of association between the
absolute or relative degree of nocturnal arterial blood pressure
reduction and the absolute or relative degree of nocturnal reduc-
tion in albuminuria. Our study suggests that impaired cardiac
autonomic nervous function (mainly lack of sympathetic with-
drawal) during sleep is an important feature of nocturnal hyper-
tension in IDDM patients with diabetic nephropathy and well-
preserved kidney function. Extracellular fluid retention was not
related significantly to the presence or absence of arterial blood
pressure dipping.
The diurnal rhythmicity of albuminuria depends on alterations
in the filtered load and/or tubular reabsorption of albumin. A
major increase in tubular protein reabsorption from day to night
is highly unlikely, since the protein reabsorption capacity is fully
saturated in protenuric patients. Furthermore, the observed
changes in the urinary /32-microglobulin excretion rate in nephro-
pathic patients cannot account for the circadian rhythm of pro-
teinuria [27]. The filtered load of albumin depends on serum
albumin concentration, the size and charge selective properties of
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Table 3. Clinical and laboratory characteristics of 47 IDDM patients
with diabetic nephropathy, divided into two groups, according to the
median value of ECV
Below Above
the median the median
N=23 N=24 P
Sex (F/M) 11/12 6/18 NS
Age years 40 (2 1—59) 38 (28—5 3) NS
Duration of diabetes years 24(15—46) 23(14—36) NS
HbA1C % 9.7 (6.7—1 2.2) 9.3 (6.5—10.9) NS
Body mass index kg m2 24.7 (19.5—32.6) 25.2 (20.8—37.1) NS
Insulin dosage 0.67 (0.34—1.24) 0.62 (0.42—0.89) NS
Ukg' day1
Duration of persistent 6 (1—17) 6 (2—19) NS
albuminuria years
Nighttime albuminuria 801 (110—2800) 1102 (81—4665) NS
pg min'
Daytime albuminuria 1043 (170—3173) 1475 (174—6719) NS
pg• min'
Nighttime systolic blood 140 (100—214) 141 (104—203) NS
pressure mm Hg
Daytime systolic blood 153 (133—193r 163 (115_187)a NS
pressure mm Hg
Night/day ratio of systolic 0.95 (0.74—1.30) 0.92 (0.71—1.10) NS
blood pressure
Nighttime diastolic blood 76 (65—1 13) 80 (57—117) NS
pressure mm Hg
Daytime diastolic blood 82 (74_98)C 87 (69—112) NS
pressure mm Hg
Night/day ratio of 0.95 (0.76—1.15) 0.91 (0.75—1.06) NS
diastolic blood
pressure
Nighttime UNaE 140 (25—417) 121 (32—289) NS
pinol min'
Daytime UNaE 117 (28—174)" 138 (41—357)" <0.06
pmolmin'
UNaE night/day ratio 1.21 (0.21—3.65) 0.88 (0.19—4.01) NS
Glomerular filtration 86 (32—124) 79 (40—1 39) NS
rate mlmin'
1.73 m2
Extracellular fluid 13.1 (11.0—14.0) 14.8 (14.0—18.5)
volume liter . 1.73 m2
Extracellular fluid 19.2 (15.1—22.9) 21.5 (17.8—27.5) <0.001
volume % of
body weight
Beat-in-to-beat 5 (1—25) 7 (0—22) NS
beats mm '
No. of patients receiving 4 6 NS
furosemide'
Furosemide dose mg daily2 140 (40—250) 350 (40—1000) NS
Data are median (range).
up < 0.01 compared to nighttime blood pressurebNS compared to nighttime urinary sodium excretion rate (UNaE)
C At time of investigation
Only patients receiving furosemide
the glomerular capillary barrier, and the transglomerular hydrau-
lic pressure difference. Before discussing the different determi-
nants it should be recalled that diurnal changes in albuminuria is
present during 24-hour recumbency and during spaced identical
meals (protein intake) [2, 28—30]. Diurnal alterations in serum
albumin concentration cannot explain the reduction in albumin-
uria from day to night in non-diabetic nephropathies [2]. Changes
in the size and charge selective properties of the glomerular
capillary wall is well documented in IDDM patients with diabetic
nephropathy [31—34]. However, we have no information on diur-
nal variations in these properties of the glomerular capillary wall
in diabetic glomerulopathy, while some patients with non-diabetic
glomerulopathies have a diurnal variation in the selectivity index
(fractional clearance of IgG/transferrin) [2, 3], the ratio being
lowest during nighttime. A redistribution of blood flow to
nephrons with different protein permeability as suggested by Arisz
[35] may contribute to the circadian rhythmicity in albuminuria, if
present in diabetic nephropathy.
Increased glomerular capillary hydraulic pressure (PGC) en-
hances the transglomerular albumin passage in diabetic and
non-diabetic animals with various experimental glomerulopathies
[36]. Conversely, acute and chronic reduction in P0 lowers
urinary albumin excretion [37]. We have previously demonstrated
that acute reduction in arterial blood pressure reduces albumin-
uria and GFR in IDDM patients suffering from diabetic nephrop-
athy [101. Recently we found a relationship between chronic
changes in MABP and changes in both albuminuria and GFR in
diabetic nephropathy [38]. The previous demonstration of im-
paired or in some cases even completely abolished autoregulation
of GFR (and probably also PGC) may aggravate the impact of
reduction in MABP on glomerular hemodynamics. Even though
our study revealed a correlation between MABP and albuminuria
both during day- and nighttime, as reported recently by Mulec et
a! [12], no relationship was demonstrated between the variation
from day to night in MABP and albuminuria. Patients with a
blunted nocturnal decline in MABP (non-dippers) had the same
degree of day to night reduction in albuminuria as did the dippers.
This finding suggests that either the arterial blood pressure
reduction was not transmitted to the glomerular capillaries,
because of changes in the ratio of the afferent/efferent arteriolar
resistance, or that other non-hemodynamic determinants of albu-
minuria offset the reducing effect of blood pressure lowering. It
should be mentioned that the circadian rhythm of GFR is not
determined by the circadian variation of MABP in diabetic
patients (B.A.C. van Acker, personal communication). However,
the diurnal variation in GFR will tend to reduce the circadian
variation in fractional albumin clearance (albuminuria GFR'
serum albumin concentration').
Twenty-four-hour blood pressure and heart rate measurements
have shown a circadian variation, characterized by a decline in
both variables during nighttime compared to daytime [39, 40].
During non-rapid eye movement sleep, this decline in blood
pressure is due to reduced cardiac output and is caused by a
reduction in heart rate and normal/reduced stroke volume, and a
decrease in peripheral resistance [41], owing to a reduction in
sympathetic tone [42—441. The diminishing in heart rate is due to
a withdrawal of sympathetic activity and an increase in parasym-
pathetic tone [21, 40]. A blunted decline in arterial blood pressure
during night has been observed in IDDM and NIDDM patients
with diabetic nephropathy [1, 7, 8]. The pathophysiological factors
responsible for this abnormal day to night variation in arterial
blood pressure in diabetic nephropathy is likely to be multifacto-
rial; latent fluid retention [121 and cardiac and neurohumoral
autonomic dysfunction may play roles in this mechanism. Our
finding of a positive correlation between the night/day ratio of
heart rate and the night/day ratio of arterial blood pressure
suggest that there is a relative lack of sympathetic withdrawal
during sleep, which might be an important feature of nocturnal
hypertension in diabetic nephropathy. This suggestion is based on
recent 24-hour ECG findings showing that diminished day/night
difference in mean RR interval, that is, heart rate, in subjects with
584 Hansen et al: BP and albuminuria in diabetic nephropathy
and without diabetic nephropathy is mainly caused by lack of
withdrawal of sympathetic activity during night [22, 23]. We found
no significant correlation between the beat-to-beat variation
during deep breathing (reflects mainly cardiac vagus activity) and
the degree of arterial blood pressure dipping.
Diabetic nephropathy is nearly always accompanied by a vary-
ing degree of extracellular fluid retention, which seems to play a
dominant role in the initiation and maintenance of arterial blood
pressure elevation in diabetic nephropathy [45]. Recently, Mulec
et at [12] demonstrated that there was no nocturnal decline in
arterial blood pressure in IDDM patients with diabetic nephrop-
athy, and an ECV above the median as compared with patients
with an ECV below the median. All patients were treated with
diuretics, one patient with hydrochlorothiazide, the others with
furosemide. Furthermore, nearly 50% received an additional
beta-blockade treatment. Their mean GFR was 39 ml min1
1.73 m2. The blunted nocturnal decline in arterial blood pressure
in patients with diabetic nephropathy could be due to a re-entry of
edema fluid into the circulation during recumbency at night,
causing an increase in intravascular volume [121. This would lead
to improved cardiac filling and cardiac output. Our data in IDDM
patients with diabetic nephropathy with well-preserved GFR
[mean (SD) 85 (27) ml min 1.73 m2] do not support the
concept that latent overhydration leads to nocturnal hypertension.
We found no significant difference in the nocturnal reduction in
arterial blood pressure in patients with an ECV below the median,
compared to patients with an ECV above the median. The risk of
overlooking a difference in nocturnal arterial blood pressure
reduction of more than + 1.7% between patients with an ECV
below and patients with an ECV above the median, is less than
5%.
Extracellular fluid volume was calculated according to the
method described by BrOchner-Mortensen [26], both in the study
of Mulec et al [12] and in the present study. The ECV [mean (SD),
14.2 (1.7) liter- 1.73 m2] in our study is similar to the ECV (14.5
liter 1.73 m2) previously reported in IDDM patients with
diabetic nephropathy and well-preserved kidney function (107 ml
• min' 1.73 rn—2) [45]. The normal values for ECV presented as
percent of body wt is 19.5% in men and 18.8% in women [46]. The
difference in ECV between patients above and below the median
value of ECV were comparable in the study of Mulec et at [12]
and in our study [ECV, mean (5EM), was 12.9 (0.2) liter - 1.73 m2
in group A and 15.4 (0.3) liter - 1.73 m2 in group B], 2.2 liter
versus 2.5 liter, respectively. Differences in the degree of impaired
kidney function and drug therapy are suggested as the most likely
explanations for the discrepancy between the past [12] and the
present studies. Enhanced nighttime sodium excretion rate has
been demonstrated in hypertensive patients with loss of nocturnal
decline in arterial blood pressure [47] and in some diabetic
patients with autonomic neuropathy [11]. Our study showed a
tendency for a reverse night/day urinary excretion rate of sodium.
In conclusion, our study indicates an association between
arterial blood pressure and albuminuria, but the mechanisms
involved in the reduction of albuminuria from day to night are
attributed largely to mechanisms other than blood pressure
changes. A relative lack of sympathetic withdrawal during sleep
seems to be an important feature of nocturnal hypertension in
diabetic nephropathy.
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